StockMarketWire.com - GlaxoSmithKline had completed the sale of Indian consumer healthcare assets including the Horlicks brands to Unilever, the companies said on Wednesday.
The deal, first announced in December 2018, included the merger of GSK's Indian listed entity and Hindustan Unilever.
GSK now owned 5.7% of Hindustan Unilever, while Unilever's interest in the business had been diluted to 61.9% from 67.2%.
At 2:27pm:
[LON:GSK] Glaxosmithkline PLC share price was -38.7p at 1475.9p
[LON:ULVR] Unilever PLC share price was -132.5p at 3943p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.